Zhengye Biotechnology Holding L (NASDAQ:ZYBT)

CN · Delayed Price · Currency is USD

1.73+0.58 (+50.45%)

Market Cap	81.99M-36.4%
Revenue (ttm)	80.05M
Net Income	-71.29M
EPS	-1.49
Shares Out	47.39M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	28,066,983
Open	1.19
Previous Close	1.15
Day's Range	1.16 - 2.89
52-Week Range	0.62 - 8.01
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

+49.58% (1D)

No price history available.

Full Chart

Alerts Compare

Insider Score

––Not scored

ZYBT Insider Score

No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.

See stocks that are scored

About ZYBT

Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.

Address

No.1 Lianmeng Road, Jilin, JI, 132101, CN

Market Cap

82 million

Employees

269

Industrial Classification

Drug Manufacturers - Specialty & Generic

1 Day

+50.45%

5 Days

+37.30%

1 Month

+10.19%

6 Months

+74.75%

1 Year

-36.40%

$ZYBT stock is featured in our Insider Trades datasets.

→ All Stock Lists

Whale Activity →

Recently reported changes in ZYBT holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by ZYBT's directors and management

No SEC Form 4 activity for ZYBT in the last 5 quarters.

Source: SEC EDGAR (Form 4)

Corporate Lobbying

ZYBT Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New ZYBT patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to ZYBT from public contracts

Source: USAspending.gov

ZYBT Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

No Insider Score for ZYBT yet — no open-market insider buys or sells in the last 90 days.

Bull Case vs Bear Case

AI-generated from ZYBT’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

No Form 4 filings in the last 90 days.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.